The healthy participant effect: insights and results from a population-based case–control study on breast cancer
American Journal of Epidemiology · 2025
DOI: 10.1093/aje/kwae155 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Epidemiology, 2025. Verfasst von Kevin Maldonado-Cañón und 7 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigaciones Clínicas, Facultad de Medicina, Universidad Nacional de Colombia, 111321, Bogotá, Colombia. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Bundesministerium für Bildung und Forschung, Deutsche Krebshilfe e.V.
Abstract (Originalsprache)
Agreement to participate in case–control studies has become low. Healthy participant bias resulting from differential response proportions in cases and controls can distort results; however, the magnitude of bias is difficult to assess. We investigated the effect in a large population-based case–control study on breast cancer, with a participation rate of 43.4% and 64.1% for controls and cases, respectively. We performed a mortality follow-up in 2020 for 3813 cases and 7335 controls recruited during 2002-2005. Standardized mortality ratios (SMRs) for overall mortality and selected causes of death were estimated. The mean age at recruitment was 63.1 years. The overall mortality for controls was 0.66 times lower (95% CI, 0.62–0.69) than for the reference population. For causes of death other than breast cancer, SMRs were similar in cases and controls (0.70 and 0.64). Higher education was associated with lower SMRs in both cases and controls. Options for adjusting the healthy participant bias are limited if the true risk factor distribution in the underlying population is unknown. However, a relevant bias in this particular case–control study is considered unlikely since a similar healthy participant effect was observed for both controls and cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Instituto de Investigaciones Clínicas, Facultad de Medicina, Universidad Nacional de Colombia, 111321, Bogotá, Colombia.
- Institute for Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
- Institute for Occupational and Maritime Medicine Hamburg, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
- Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
- Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
- Institute of Global Health, University Hospital Heidelberg, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany.
ORCID-Profile: Kevin Maldonado-Cañón, Annika Möhl, Nadia Obi, Sabine Behrens, Fabian Flaßkamp, Petra Seibold, Jenny Chang-Claude, Heiko Becher
Förderung
- Bundesministerium für Bildung und Forschung
- Deutsche Krebshilfe e.V
Zitieren
APA
Maldonado-Cañón, K., Möhl, A., Obi, N., Behrens, S., Flaßkamp, F., Seibold, P., Chang-Claude, J., & Becher, H. (2025). The healthy participant effect: insights and results from a population-based case–control study on breast cancer. American Journal of Epidemiology. https://doi.org/10.1093/aje/kwae155
Vancouver
Maldonado-Cañón K, Möhl A, Obi N, Behrens S, Flaßkamp F, Seibold P, et al. The healthy participant effect: insights and results from a population-based case–control study on breast cancer. American Journal of Epidemiology. 2025. doi:10.1093/aje/kwae155
BibTeX
@article{MaldonadoCan2025,
author = {Maldonado-Cañón, Kevin and Möhl, Annika and Obi, Nadia and Behrens, Sabine and Flaßkamp, Fabian and Seibold, Petra and Chang-Claude, Jenny and Becher, Heiko},
title = {The healthy participant effect: insights and results from a population-based case–control study on breast cancer},
journal = {American Journal of Epidemiology},
year = {2025},
doi = {10.1093/aje/kwae155}
}
EUVIMED